Form 8-K - Current report:
SEC Accession No. 0001437749-24-026409
Filing Date
2024-08-13
Accepted
2024-08-13 16:23:27
Documents
15
Period of Report
2024-08-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cyan20240813_8k.htm   iXBRL 8-K 28810
2 EXHIBIT 10.1 ex_714306.htm EX-10.1 17206
  Complete submission text file 0001437749-24-026409.txt   174129

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cyan-20240809.xsd EX-101.SCH 3409
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cyan-20240809_def.xml EX-101.DEF 10736
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cyan-20240809_lab.xml EX-101.LAB 14384
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cyan-20240809_pre.xml EX-101.PRE 10786
17 EXTRACTED XBRL INSTANCE DOCUMENT cyan20240813_8k_htm.xml XML 2672
Mailing Address 73-4460 QUEEN KAAHUMANU HWY SUITE 102 KAILUA-KONA HI 96740
Business Address 73-4460 QUEEN KAAHUMANU HWY SUITE 102 KAILUA KONA HI 96740 8083261353
CYANOTECH CORP (Filer) CIK: 0000768408 (see all company filings)

EIN.: 911206026 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 000-14602 | Film No.: 241201886
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)